Statistics

Total Visits

Views
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort24

File Visits

Downloads
1935.pdf19

Select a period of time:

Number of views in the range

Views
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort18

Number of downloads in the range

Downloads
1935.pdf17

Views

Views
November 20253
December 20250
January 20260
February 20260
March 20262
April 202610
May 20263
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • November 2025
    0
  • December 2025
    0
  • January 2026
    4
  • February 2026
    3
  • March 2026
    4
  • April 2026
    3
  • May 2026
    3
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Spain3
Brazil2
Angola2
Argentina1
Australia1
Colombia1
Ecuador1
Turkey1
 

Top countries by downloads

Downloads
United States11
Colombia1
 

Top cities views

Views
Bursa1
Canavieiras1
Charlotte1
Comodoro Rivadavia1
Huesca1
Luanda1
Madrid1
Medellín1
Palma1
Parauapebas1
 

Top cities by downloads

Downloads